Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Contineum Therapeutics, Inc. Class A (CTNM – Research Report ... Morgan Stanley also maintained a Buy rating on the stock with a $25.00 ...

Buy CTNM near 16.07 target 18.76 stop loss @ 16.02 Details The technical summary data tells us to buy CTNM near 16.07 with an ...

CNR stock has long been a top stock, with a solid position in a railway duopoly. But right now is a great time to buy with ...

On Wednesday, Core & Main Inc (CNM) stock saw a modest uptick, ending the day at $47.12 which represents a slight increase of $2.37 or 5.30% from the prior close of $44.75. The stock opened at $46.92 ...

CTM Stock Performance and Moving Averages. In recent trading, Castellum Inc (CTM) stock price has shown some volatility, fluctuating 2.27% over the last five trades and -8.96% ove ...

Read about Contango Ore's transition to revenue generation through gold production at Manh Choh Mine and future projects.

And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Christopher M. Killian, SVP & CTO at Eastman Chemical EMN, executed a substantial insider sell on November 7, according to an SEC filing. What Happened: Killian's decision to sell 3,061 shares of ...

U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Non-Cum. Perp. Pfd. Series K)-0.89% U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L)-1.90% U.S. Bancorp Dep. Pfd ...